Patents by Inventor James S. Wright

James S. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250054644
    Abstract: The present disclosure describes various aspects of remote presence interfaces (RPIs) for use on portable electronic devices (PEDs) to interface with remote presence devices. An RPI may allow a user to interact with a telepresence device, view a live video feed, provide navigational instructions, and/or otherwise interact with the telepresence device. The RPI may allow a user to manually, semi-autonomously, or autonomously control the movement of the telepresence device. One or more panels associated with a video feed, patient data, calendars, date, time, telemetry data, PED data, telepresence device data, healthcare facility information, healthcare practitioner information, menu tabs, settings controls, and/or other features may be utilized via the RPI.
    Type: Application
    Filed: October 21, 2024
    Publication date: February 13, 2025
    Applicants: Teladoc Health, Inc., iRobot Corporation
    Inventors: Charles S. Jordan, Andy Young, Mei Sheng Ng, Yair Lurie, Fuji Lai, Timothy C. Wright, Cody Herzog, Blair Whitney, Bill Rizzi, James Ballantyne, Yulun Wang, Cheuk Wah Wong, Justin H. Kearns, Orjeta Taka, Ramchandra Karandikar
  • Publication number: 20250034333
    Abstract: An example of a three-dimensional (3D) printing kit includes a build material composition and a fusing agent to be applied to at least a portion of the build material composition during 3D printing. The build material composition includes a semi-crystalline thermoplastic polymer having a surface energy density greater than 41 mN/m. The fusing agent includes an energy absorber to absorb electromagnetic radiation to coalesce the semi-crystalline thermoplastic polymer in the at least the portion.
    Type: Application
    Filed: October 4, 2024
    Publication date: January 30, 2025
    Inventors: Ali Emamjomeh, Shannon Reuben Woodruff, Kenneth Flack, Greg S. Long, Katrina Donovan, Erica Fung, Jacob Tyler Wright, James W. Stasiak
  • Patent number: 8952073
    Abstract: The presently disclosed and claimed inventive concept(s) provides new estrogenic compounds of the general formula and pharmaceutical compositions containing them. The compounds of the presently disclosed and claimed inventive concept(s) are useful, for example, in hormone replacement therapies (HRT/ERT), and as contraceptives, and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the presently disclosed and claimed inventive concept(s).
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: February 10, 2015
    Assignee: University of Ottawa
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim, Christine Pratt
  • Publication number: 20130274344
    Abstract: The presently disclosed and claimed inventive concept(s) provides new estrogenic compounds of the general formula and pharmaceutical compositions containing them. The compounds of the presently disclosed and claimed inventive concept(s) are useful, for example, in hormone replacement therapies (HRT/ERT), and as contraceptives, and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the presently disclosed and claimed inventive concept(s).
    Type: Application
    Filed: June 7, 2013
    Publication date: October 17, 2013
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim, Christine Pratt
  • Patent number: 8471073
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: June 25, 2013
    Assignee: University of Ottawa
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Publication number: 20120190898
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Application
    Filed: March 27, 2012
    Publication date: July 26, 2012
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Patent number: 8158684
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: April 17, 2012
    Assignee: University of Ottawa
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Publication number: 20110196045
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Application
    Filed: April 21, 2011
    Publication date: August 11, 2011
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Publication number: 20090234024
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Application
    Filed: February 4, 2009
    Publication date: September 17, 2009
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim